CLOs on the Move

Bayer Pharmaceutical Manufacturing Services

www.bayerpharmamfgservices.com

 
Bayer Pharmaceutical Manufacturing Services is a Shawnee, KS-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Siegfried USA

Siegfried USA is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Pennsville, NJ. To find more information about Siegfried USA, please visit www.siegfried-usa.com

Premier Healthcare Professionals

Premier Healthcare Professionals is a Cumming, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

On Belay Health Solutions

On Belay Health Solutions is a company that supports independent primary care physicians in their quest to access meaningful value-based contracts and provides the clinical support necessary to succeed and maintain their independence.

Max Neeman International

Max Neeman International is a Cary, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Accord BioPharma

Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.